Experts Suggest Whistleblower Hotlines For Reporting Data Integrity Problems
This article was originally published in The Pink Sheet Daily
Executive Summary
Pharmaceutical manufacturers need to have whistleblower hotlines in place where employees can anonymously report data integrity problems without fear of reprisal.
You may also be interested in...
Justice Targets ‘Serious’ GMP Issues, Hears More from Whistleblowers
The Justice Department is imposing harsh penalties on manufacturers that commit serious GMP violations and this trend will continue in the foreseeable future. DOJ is also getting more calls from FDA and whistleblowers alleging GMP violations under the False Claims Act.
Program Participants Urge The FDA To Adopt Some Pharmaceutical Quality Metrics And Avoid Others
Site-based metrics praised; lot acceptance rates, invalidated OOS rates discouraged. Agency official admits some proposed metrics were “not the best.”
EU GMP Annex I Is A Top Priority For EMA While Industry Has Lingering Concerns
Questions about contamination control strategy raised as European Medicines Agency makes EU GMP Annex I revision a top priority in its 2021 work plan.